Incorporated in 2018, Fabtech Technologies Ltd is a biopharma engineering company.
The company designs and delivers turnkey projects, including cleanroom facilities, modular systems, and customized engineering solutions.
It provides end-to-end services such as design, engineering, manufacturing, installation, and project management. With expertise in cleanroom technology, HVAC systems, and process equipment, Fabtech serves global clients, ensuring compliance with international regulatory standards.
Services:
As of July 31, 2025, the company had 185 permanent employees.
Competitive Strengths:
| Investory Category | Subscription Percentage | Amount Raised (₹ Crores) |
|---|---|---|
| Qualified Institutional Buyers (QIBs) | 50% | 60,30,000 crores |
| Non-Institutional Investors (NIIs) | 15% | 18,09,000 crores |
| Retail Individual Investors (RIIs) | 35% | 42,21,000 crores |
| Allotment Date | Listing Date | Refund Date |
|---|---|---|
| 03 Oct '25 | 07 Oct '25 | 06 Oct '25 |
| Issue Composition: | |
|---|---|
| Face Value | ₹0 per share |
| Total Issue Size | 1,20,60,000 shares (aggregating up to ₹14,325 crores) |
| Fresh Issue | NaN shares (aggregating up to To be announced) |
| Offer for Sale | NaN shares of ₹0 (aggregating up to To be announced) |
| Issue Type | |
| Post-Issue Shareholding Pattern: | |
|---|---|
| Pre-Issue Shareholding | shares |
| Post-Issue Shareholding | 0 shares |
| Minimum Lot Size | -- |
| Maximum Lot Size (Retail) | -- |
The lot size of Fabtech Technologies ipo has been designed to ensure broad participation while maintaining optimal price discovery.
| Book Running Lead Manager(s) |
|---|